title: Epidermal growth factor receptor in non-small cell lung cancer.
abstract: Following the identification of a group of patients in the initial tyrosine kinase inhibitor (TKI) trials for lung cancer, there has been detailed focus on which patients may benefit from inhibitor therapy. This article reviews the background, genetics and prevalence of epidermal growth factor mutations in non-small cell lung cancer (NSCLC). Additionally, the prevalence in unselected patients is compared against various other reviews.
authors: Department of Respiratory Medicine, Royal Prince Alfred Hospital, NSW 2050, Australia.
authors: Charles N
authors: CN
authors: Prabhakar
keywords: Lung neoplasms; carcinoma; epidermal growth factor; non-small cell lung cancer (NSCLC); receptor